Which stocks are best to buy now? According to top Wall Street analysts, the three stocks listed below are Strong Buys. Each stock received a new Buy rating today and has a significant upside as well.
To find more stocks like these, take a look at TipRanks’ Analyst Top Stocks tool. It shows you a real-time list of all stocks that have been recently rated by top-ranking analysts.
Here are today’s top stock picks, according to analysts. Click on any ticker to thoroughly research the stock before you decide whether to add it to your portfolio.
Pliant Therapeutics (NASDAQ:PLRX) – The clinical-stage biopharma company is focused on developing novel therapies for the treatment of fibrosis. Today, analyst Edward Nash of Canaccord Genuity initiated a Buy rating on PLRX stock with a price target of $48. Overall, the consensus 12-month price target of all eight top analysts who recently rated the stock a Buy, implies an impressive upside of 127%.
Agilon Health (NYSE:AGL) – The company enables physicians to create their own Medicare-focused, capitated line of business. Today, Deutsche Bank analyst George Hill reiterated a Buy rating on AGL stock with a price target of $27. Overall, the consensus 12-month price target of all eight top analysts who recently rated the stock a Buy, implies an upside of 39.2%.
Ritchie Bros. (NYSE:RBA) – Ritchie is an industrial auctioneer that engages in the sale of equipment to on-site and online bidders. Today, National Bank analyst Maxim Sytchev upgraded the rating on RBA stock to Buy with a price target of $61. Overall, the consensus 12-month price target of the three out of four top analysts who recently rated the stock a Buy, implies an upside of 30.4%.
Who are the Top Analysts?
TipRanks ranks financial analysts according to the success rates of their ratings and the average return on each of their ratings. See real-time analyst rankings and learn more about the performance of top analysts on TipRanks’ Top Wall Street Analysts page.
